Table 1 Relationship between SPRY4-IT1 expression and clinicopathological features in patients with ESCC
Features(N) | SPRY4-IT1 expression level | P value | |
|---|---|---|---|
High(n = 47) | Low(n = 45) | ||
Age group | P = 0.686 | ||
≤ 60 | 26 | 23 | |
>60 | 21 | 22 | |
Gender | P = 0.549 | ||
Male | 29 | 25 | |
Female | 18 | 20 | |
Smoking status | P = 0.537 | ||
Ever and current | 26 | 22 | |
Never | 21 | 23 | |
Alcohol consumption | P = 0.525 | ||
Ever and current | 24 | 20 | |
Never | 23 | 25 | |
Tumor location | P = 0.808 | ||
Upper | 9 | 7 | |
Middle | 22 | 24 | |
Lower | 16 | 14 | |
Differentiation | P = 0.029 | ||
Well | 7 | 16 | |
Moderate | 21 | 20 | |
Poor | 19 | 9 | |
T classification | P = 0.013 | ||
Tis-2 | 16 | 27 | |
T3–4 | 31 | 18 | |
Lymph node metastasis | P = 0.022 | ||
Yes | 32 | 20 | |
No | 15 | 25 | |
Pathological stage | P = 0.001 | ||
Stage I | 10 | 25 | |
Stage II-III | 37 | 20 | |
Lymph node recurrence | P = 0.077 | ||
Yes | 38 | 29 | |
No | 9 | 16 | |